592 related articles for article (PubMed ID: 11797073)
1. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
Parrott AC; Milani RM; Parmar R; Turner JD
Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
[TBL] [Abstract][Full Text] [Related]
2. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.
Parrott AC; Sisk E; Turner JJ
Drug Alcohol Depend; 2000 Jul; 60(1):105-10. PubMed ID: 10821995
[TBL] [Abstract][Full Text] [Related]
3. Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation.
Daumann J; Hensen G; Thimm B; Rezk M; Till B; Gouzoulis-Mayfrank E
Psychopharmacology (Berl); 2004 May; 173(3-4):398-404. PubMed ID: 14722704
[TBL] [Abstract][Full Text] [Related]
4. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
Soar K; Parrott A; Turner J
J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
[TBL] [Abstract][Full Text] [Related]
5. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
Soar K; Turner JJ; Parrott AC
J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
[TBL] [Abstract][Full Text] [Related]
6. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.
Parrott AC; Buchanan T; Scholey AB; Heffernan T; Ling J; Rodgers J
Hum Psychopharmacol; 2002 Aug; 17(6):309-12. PubMed ID: 12404677
[TBL] [Abstract][Full Text] [Related]
7. Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms?
Guillot C
J Psychoactive Drugs; 2007 Mar; 39(1):31-9. PubMed ID: 17523583
[TBL] [Abstract][Full Text] [Related]
8. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
Milani RM; Parrott AC; Schifano F; Turner JJ
Hum Psychopharmacol; 2005 Jun; 20(4):249-61. PubMed ID: 15816011
[TBL] [Abstract][Full Text] [Related]
9. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
[TBL] [Abstract][Full Text] [Related]
10. Adult attention deficit hyperactivity disorder and other psychiatric symptoms in recreational polydrug users.
Parrott AC; Hatton NP; Rowe KL; Watts LA; Donev R; Kissling C; Thome J
Hum Psychopharmacol; 2012 Mar; 27(2):209-16. PubMed ID: 22389085
[TBL] [Abstract][Full Text] [Related]
11. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
12. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
Parrott AC
J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
[TBL] [Abstract][Full Text] [Related]
13. Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users.
Parrott AC; Rodgers J; Buchanan T; Ling J; Heffernan T; Scholey AB
Hum Psychopharmacol; 2006 Jul; 21(5):285-98. PubMed ID: 16856221
[TBL] [Abstract][Full Text] [Related]
14. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
Morgan MJ; McFie L; Fleetwood H; Robinson JA
Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
[TBL] [Abstract][Full Text] [Related]
15. Everyday and prospective memory deficits in ecstasy/polydrug users.
Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
J Psychopharmacol; 2011 Apr; 25(4):453-64. PubMed ID: 20123936
[TBL] [Abstract][Full Text] [Related]
16. Memory deficits associated with recreational use of "ecstasy" (MDMA).
Morgan MJ
Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
[TBL] [Abstract][Full Text] [Related]
17. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
18. Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users.
Wetherell MA; Montgomery C
Psychopharmacology (Berl); 2014 Apr; 231(7):1365-75. PubMed ID: 24190587
[TBL] [Abstract][Full Text] [Related]
19. Recreational ecstasy use and depression.
Guillot C; Greenway D
J Psychopharmacol; 2006 May; 20(3):411-6. PubMed ID: 16574715
[TBL] [Abstract][Full Text] [Related]
20. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
Bedi G; Van Dam NT; Redman J
J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
